KODIAK SCIENCES INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
KODIAK SCIENCES INC. (KOD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 21.69 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 21.69M shares, a 7.81% increase year-over-year.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 22.19M shares, a 11.56% increase year-over-year.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 23.11M shares, a 11.07% increase year-over-year.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 20.11M shares, a 12.54% increase year-over-year.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 22.38M shares, a 11.69% increase from fiscal 2024.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 20.04M shares, a 12.35% increase from fiscal 2023.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 17.84M shares, a 6.03% increase from fiscal 2022.
- KODIAK SCIENCES INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 16.82M shares, a 13.00% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 21.69M shares 10-Q · filed 2026-08-13 | 21.69M shares 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | 22.19M shares 10-Q · filed 2026-05-07 | |||||||
| 2025-12-31 | 22.38M shares 10-K · filed 2026-03-31 | |||||||
| 2025-09-30 | 23.11M shares 10-Q · filed 2025-11-13 | 23.11M shares 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | 20.11M shares 10-Q · filed 2026-08-13 | 20.11M shares 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | 19.89M shares 10-Q · filed 2026-05-07 | |||||||
| 2024-12-31 | 20.04M shares 10-K · filed 2026-03-31 | 19.99M shares 10-K · filed 2025-03-27 | ||||||
| 2024-09-30 | 20.81M shares 10-Q · filed 2025-11-13 | 20.81M shares 10-Q · filed 2025-11-13 | 20.78M shares 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | 17.87M shares 10-Q · filed 2025-08-13 | 17.87M shares 10-Q · filed 2025-08-13 | 17.85M shares 10-Q · filed 2024-08-14 | |||||
| 2024-03-31 | 17.54M shares 10-Q · filed 2025-05-14 | 17.47M shares 10-Q · filed 2024-05-15 | ||||||
| 2023-12-31 | 17.84M shares 10-K · filed 2026-03-31 | 17.77M shares 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | 18.82M shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 19.96M shares 10-Q · filed 2024-08-14 | |||||||
| 2023-03-31 | 16.85M shares 10-Q · filed 2024-05-15 | |||||||
| 2022-12-31 | 16.82M shares 10-K · filed 2025-03-27 | |||||||
| 2022-09-30 | 16.91M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 14.53M shares 10-Q · filed 2023-08-14 | |||||||
| 2022-03-31 | 14.70M shares 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | 14.89M shares 10-K · filed 2024-03-28 | |||||||
| 2021-09-30 | 8.21M shares 10-Q · filed 2022-11-09 | |||||||
| 2021-06-30 | 7.11M shares 10-Q · filed 2022-08-09 | |||||||
| 2021-03-31 | 7.37M shares 10-Q · filed 2022-05-10 | |||||||
| 2020-12-31 | 7.26M shares 10-K · filed 2023-03-28 | |||||||
| 2020-09-30 | 7.60M shares 10-Q · filed 2021-11-09 | |||||||
| 2020-06-30 | 7.62M shares 10-Q · filed 2021-08-09 | |||||||
| 2020-03-31 | 6.88M shares 10-Q · filed 2021-05-10 | |||||||
| 2019-12-31 | 6.83M shares 10-K · filed 2022-03-01 | |||||||
| 2019-09-30 | 6.09M shares 10-Q · filed 2020-11-09 | |||||||
| 2019-06-30 | 5.48M shares 10-Q · filed 2020-08-10 | |||||||
| 2019-03-31 | 5.08M shares 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | 5.19M shares 10-K · filed 2021-03-01 | |||||||
| 2018-09-30 | 23.77M shares 10-Q · filed 2019-11-12 | |||||||
| 2018-06-30 | 23.16M shares 10-Q · filed 2019-08-14 | |||||||
| 2018-03-31 | 20.80M shares 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | 16.54M shares 10-K · filed 2020-03-16 | |||||||
| 2017-09-30 | 16.47M shares 10-Q · filed 2018-11-16 | |||||||
| 2016-12-31 | 14.22M shares 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |